Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if 20mg BID of Rabeprazole is effective in controlling GERD in patients with concomitant bronchial asthma and to assess improvement in asthma after reflux control.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ponce Gastroenterology Research
• Collaborator: PriCara, Unit of Ortho-McNeil, Inc.
• Treatments: Rabeprazole

Criteria

Inclusion Criteria:

• Moderate Persistent or moderate severe bronchial asthma as determined by the study pulmonologist

• Gastroesophageal Reflux disease

Exclusion Criteria:

• History of hypersensitivity to rabeprazole or its metabolites